Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Becton Dickinson 4.983.
Vertex Pharmaceuticals vs Becton Dickinson Net Worth and Market Cap
Vertex Pharmaceuticals (VRTX) and Becton Dickinson (BDX) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $5.0B for Becton Dickinson. Becton Dickinson leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 46.5% for Becton Dickinson. Vertex Pharmaceuticals's net margin is 33.0% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Becton Dickinson.| Metric | Vertex Pharmaceuticals | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $4.98B |
| Cost of Revenue | $489.00M | $2.67B |
| Gross Profit | $2.85B | $2.31B |
| Operating Income | $1.25B | $663.00M |
| Net Income | $1.10B | $377.00M |
| R&D Expense | $994.00M | $258.00M |
| Earnings Per Share | $4.31 | $1.37 |
| Gross Margin | 85.3% | 46.5% |
| Operating Margin | 37.4% | 13.3% |
| Net Profit Margin | 33.0% | 7.6% |
| Free Cash Flow | $1.01B | $509.00M |
| Cumulative Free Cash Flow | $17.24B | $39.60B |
| Operating Cash Flow | $1.13B | $652.00M |
| Cash & Equivalents | $6.14B | $708.00M |